MYCN and neuroblastoma: Multiple biomarkers have been implicated in the prognosis of neuroblastoma, including N-myc amplification, DNA ploidy, Ferritin levels, neuron specific enolase, loss of chromosomes 1p, 11q or gain of 17q as well as TrkA and MDR associated proteins.